These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19533034)

  • 1. Disulfide bond as a structural determinant of prion protein membrane insertion.
    Shin JY; Shin JI; Kim JS; Yang YS; Shin YK; Kim KK; Lee S; Kweon DH
    Mol Cells; 2009 Jun; 27(6):673-80. PubMed ID: 19533034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep membrane insertion of prion protein upon reduction of disulfide bond.
    Shin JI; Shin JY; Kim JS; Yang YS; Shin YK; Kweon DH
    Biochem Biophys Res Commun; 2008 Dec; 377(3):995-1000. PubMed ID: 18955027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the disulfide bond in prion protein conversion.
    Herrmann LM; Caughey B
    Neuroreport; 1998 Aug; 9(11):2457-61. PubMed ID: 9721914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfide mapping reveals the domain swapping as the crucial process of the structural conversion of prion protein.
    Hafner-Bratkovič I; Jerala R
    Prion; 2011; 5(2):56-9. PubMed ID: 21555920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
    Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
    J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
    Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
    Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
    Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
    J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Cys179-Cys214 disulfide bond in the stability and folding of prion protein: insights from molecular dynamics simulations.
    Ning L; Guo J; Jin N; Liu H; Yao X
    J Mol Model; 2014 Feb; 20(2):2106. PubMed ID: 24515720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of prion protein to lipid membranes and implications for prion conversion.
    Sanghera N; Pinheiro TJ
    J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the human prion protein reveals a mechanism for oligomerization.
    Knaus KJ; Morillas M; Swietnicki W; Malone M; Surewicz WK; Yee VC
    Nat Struct Biol; 2001 Sep; 8(9):770-4. PubMed ID: 11524679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
    Lee S; Eisenberg D
    Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion.
    Hafner-Bratkovic I; Bester R; Pristovsek P; Gaedtke L; Veranic P; Gaspersic J; Mancek-Keber M; Avbelj M; Polymenidou M; Julius C; Aguzzi A; Vorberg I; Jerala R
    J Biol Chem; 2011 Apr; 286(14):12149-56. PubMed ID: 21324909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
    Tabrett CA; Harrison CF; Schmidt B; Bellingham SA; Hardy T; Sanejouand YH; Hill AF; Hogg PJ
    Biochem J; 2010 May; 428(2):169-82. PubMed ID: 20337594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin converts the Syrian hamster (29-231) recombinant prion protein to an insoluble form.
    Requena JR; Levine RL
    Free Radic Biol Med; 2001 Jan; 30(2):141-7. PubMed ID: 11163530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational stability of Syrian hamster prion protein PrP(90-231).
    Grabenauer M; Wyttenbach T; Sanghera N; Slade SE; Pinheiro TJ; Scrivens JH; Bowers MT
    J Am Chem Soc; 2010 Jul; 132(26):8816-8. PubMed ID: 20536231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramolecular versus intermolecular disulfide bonds in prion proteins.
    Welker E; Raymond LD; Scheraga HA; Caughey B
    J Biol Chem; 2002 Sep; 277(36):33477-81. PubMed ID: 12082114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway complexity of prion protein assembly into amyloid.
    Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
    J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.